These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9181584)

  • 41. Of mice and men: the ethics of patenting animals.
    Morin E
    Health Law J; 1997; 5():147-97. PubMed ID: 10569897
    [No Abstract]   [Full Text] [Related]  

  • 42. Patenting transgenics in the European Union.
    Baggot B
    Nat Biotechnol; 1998 Mar; 16(3):299-301. PubMed ID: 9528013
    [No Abstract]   [Full Text] [Related]  

  • 43. The patenting of novel biotech products.
    Webber PM
    IDrugs; 2007 Jul; 10(7):459-62. PubMed ID: 17642015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Religious voices in biotechnology: the case of gene patenting.
    Hanson MJ
    Genetic Resour; 1999; 12(1-2):5-22. PubMed ID: 12962106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bioartificiality thresholds: oscillations of genetic patenting].
    Tallacchini M
    Rev Derecho Genoma Hum; 2003; (18):115-36. PubMed ID: 14562472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.
    Spranger TM
    IIC Int Rev Ind Prop Copyr Law; 2000 Jun; 31(4):373-80. PubMed ID: 12956125
    [No Abstract]   [Full Text] [Related]  

  • 47. Are ESTs patentable?
    Auth DR
    Nat Biotechnol; 1997 Sep; 15(9):911-2. PubMed ID: 9306410
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin patent dispute revisits old biotechnology battleground.
    Fox JL
    Nat Biotechnol; 1997 Apr; 15(4):307. PubMed ID: 9094114
    [No Abstract]   [Full Text] [Related]  

  • 49. Brave new industry, that has such patents in it! Reflections on the economic consequences of patenting DNA.
    Cockburn IM
    Adv Genet; 2003; 50():385-98; discussion 507-10. PubMed ID: 14714701
    [No Abstract]   [Full Text] [Related]  

  • 50. Patenting pieces of people.
    Nat Biotechnol; 2003 Apr; 21(4):341. PubMed ID: 12665804
    [No Abstract]   [Full Text] [Related]  

  • 51. Biotechnology patents: strategies for meeting economic and ethical concerns.
    Gold ER
    Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
    [No Abstract]   [Full Text] [Related]  

  • 52. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 53. How many lawyers does it take...greed and legal wrangling could stifle the medical revolution.
    New Sci; 2002 May; 174(2343):3. PubMed ID: 12731531
    [No Abstract]   [Full Text] [Related]  

  • 54. Religious voices in biotechnology: the case of gene patenting.
    Hanson MJ
    Hastings Cent Rep; 1997; 27(6):suppl 1-21. PubMed ID: 9474493
    [No Abstract]   [Full Text] [Related]  

  • 55. US acts to lengthen term of patents to help biotechnology.
    Wadman M
    Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149
    [No Abstract]   [Full Text] [Related]  

  • 56. Patents on genes: clarifying the issues.
    Crespi RS
    Nat Biotechnol; 2000 Jun; 18(6):683-4. PubMed ID: 10835611
    [No Abstract]   [Full Text] [Related]  

  • 57. Patenting of genetic material: are the benefits to society being realized?
    Willison DJ; MacLeod SM
    CMAJ; 2002 Aug; 167(3):259-62. PubMed ID: 12186174
    [No Abstract]   [Full Text] [Related]  

  • 58. European Commission rethinks biotech patents.
    Mitchell P
    Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
    [No Abstract]   [Full Text] [Related]  

  • 59. Why Cabilly must stand.
    Scheller RH
    Nat Biotechnol; 2007 Oct; 25(10):1088-9. PubMed ID: 17921986
    [No Abstract]   [Full Text] [Related]  

  • 60. Churches say no to gene patenting.
    Christ Century; 2000 Sep; 117(25):899-900. PubMed ID: 12528735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.